MENTORNCT07410052
Microbiome-Targeted Enhancement of Neurocognition With Probiotics-Riboflavin Combination
StatusActive, Not Recruiting
PhaseNot applicable
Primary completion (estimated)
At risk: Primary completion moved 5 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 19 words Show 5 more changesShow less
- Trial status changed: Not Yet Recruiting → Active, Not Recruiting
- Primary completion pushed from Jul 15, 2027 to Dec 15, 2027
- Study completion pushed from Aug 15, 2027 to Feb 15, 2028
- Study sites: 0 to 1
- Secondary endpoints: details revised at 2 of 4 entries
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Montreal Cognitive Assesment scores
Timeframe: Change from baseline The Montreal Cognitive Assessment (MoCA) score at 12 weeks
Secondary (4)
Mini-Mental State Examination Score
Pittsburgh Sleep Quality Index (PSQI)
Brain oxygen saturation
Grip strength
Arms and interventions
Experimental 1Experimental
2 capsules of probiotic and riboflavin cellulose per day
Experimental 2Placebo comparator
2 capsules of microcrystaline cellulose per day
Dietary supplements: Experimental 1, Experimental 2
Sites
1 site in 1 country
- Center for Health SciencesBelgrade, Serbia